{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:21:19Z","timestamp":1769502079775,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T00:00:00Z","timestamp":1334793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1475-2840-11-35","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T14:30:50Z","timestamp":1334845850000},"source":"Crossref","is-referenced-by-count":12,"title":["Baseline comparison of three health utility measures and the feeling thermometer among participants in the action to control cardiovascular risk in diabetes trial"],"prefix":"10.1186","volume":"11","author":[{"given":"Dennis W","family":"Raisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Feeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"David C","family":"Goff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KM Venkat","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don G","family":"Hire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,19]]},"reference":[{"issue":"2","key":"467_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2165\/00019053-200017020-00004","volume":"17","author":"C Green","year":"2000","unstructured":"Green C, Brazier J, Deverill M: Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics. 2000, 17 (2): 151-165. 10.2165\/00019053-200017020-00004.","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"467_CR2","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/j.1464-5491.2007.02188.x","volume":"24","author":"WJ Valentine","year":"2007","unstructured":"Valentine WJ, Bottomley JM, Palmer AJ, Brandle M, Foos V, Williams R, Dormandy JA, Yates J, Tan MH, Massi-Benedetti M: PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK. Diabet Med. 2007, 24 (9): 982-1002. 10.1111\/j.1464-5491.2007.02188.x.","journal-title":"Diabet Med"},{"issue":"6","key":"467_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2165\/00019053-199507060-00004","volume":"7","author":"D Feeny","year":"1995","unstructured":"Feeny D, Furlong W, Boyle M, Torrance GW: Multi-attribute health status classification systems, Health Utilities Index. Pharmacoeconomics. 1995, 7 (6): 490-502. 10.2165\/00019053-199507060-00004.","journal-title":"Pharmacoeconomics"},{"issue":"7133","key":"467_CR4","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/bmj.316.7133.736","volume":"316","author":"P Kind","year":"1998","unstructured":"Kind P, Dolan P, Gudex C, Williams A: Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ. 1998, 316 (7133): 736-741. 10.1136\/bmj.316.7133.736.","journal-title":"BMJ"},{"issue":"9","key":"467_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/01.mlr.0000135827.18610.0d","volume":"42","author":"JE Brazier","year":"2004","unstructured":"Brazier JE, Roberts J: The estimation of a preference-based measure of health from the SF-12. Med Care. 2004, 42 (9): 851-859. 10.1097\/01.mlr.0000135827.18610.0d.","journal-title":"Med Care"},{"issue":"11","key":"467_CR6","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/00005650-200411000-00013","volume":"42","author":"HJ Schunemann","year":"2004","unstructured":"Schunemann HJ, Armstrong D, Degl'innocenti A, Wiklund I, Fallone CA, Tanser L, Van Zanten SV, Heels-Ansdell D, El-Dika S, Chiba N, et al: A randomized multicenter trial to evaluate simple utility elicitation techniques in patients with gastroesophageal reflux disease. Med Care. 2004, 42 (11): 1132-1142. 10.1097\/00005650-200411000-00013.","journal-title":"Med Care"},{"issue":"2","key":"467_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1177\/0272989X03251243","volume":"23","author":"HJ Schunemann","year":"2003","unstructured":"Schunemann HJ, Griffith L, Stubbing D, Goldstein R, Guyatt GH: A clinical trial to evaluate the measurement properties of 2 direct preference instruments administered with and without hypothetical marker states. Med Decis Making. 2003, 23 (2): 140-149. 10.1177\/0272989X03251243.","journal-title":"Med Decis Making"},{"issue":"2","key":"467_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1017\/S0266462306051051","volume":"22","author":"P Rasanen","year":"2006","unstructured":"Rasanen P, Roine E, Sintonen H, Semberg-Konttinen V, Ryynanen OP, Roine R: Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review. Int J Technol Assess Health Care. 2006, 22 (2): 235-241.","journal-title":"Int J Technol Assess Health Care"},{"issue":"3","key":"467_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1586\/14737167.3.3.293","volume":"3","author":"J Brazier","year":"2003","unstructured":"Brazier J, Green C, McCabe C, Stevens K: Use of visual analog scales in economic evaluation. Expert Rev Pharmacoecon Outcomes Res. 2003, 3 (3): 293-302. 10.1586\/14737167.3.3.293.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"8","key":"467_CR10","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3899\/jrheum.110404","volume":"38","author":"MJ Harrison","year":"2011","unstructured":"Harrison MJ, Bansback NJ, Marra CA, Drummond M, Tugwell PS, Boonen A: Valuing health for clinical and economic decisions: directions relevant for rheumatologists. J Rheumatol. 2011, 38 (8): 1770-1775. 10.3899\/jrheum.110404.","journal-title":"J Rheumatol"},{"issue":"7","key":"467_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/hec.1086","volume":"15","author":"D Parkin","year":"2006","unstructured":"Parkin D, Devlin N: Is there a case for using visual analogue scale valuations in cost-utility analysis?. Health Econ. 2006, 15 (7): 653-664. 10.1002\/hec.1086.","journal-title":"Health Econ"},{"issue":"4","key":"467_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/02729890122062622","volume":"21","author":"GW Torrance","year":"2001","unstructured":"Torrance GW, Feeny D, Furlong W: Visual analog scales: do they have a role in the measurement of preferences for health states?. Med Decis Making. 2001, 21 (4): 329-334.","journal-title":"Med Decis Making"},{"key":"467_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1477-7525-4-25","volume":"4","author":"AA Rashidi","year":"2006","unstructured":"Rashidi AA, Anis AH, Marra CA: Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients. Health Qual Life Outcomes. 2006, 4: 25-10.1186\/1477-7525-4-25.","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"467_CR14","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1524-4733.2004.75011.x","volume":"7","author":"HT Hatoum","year":"2004","unstructured":"Hatoum HT, Brazier JE, Akhras KS: Comparison of the HUI3 with the SF-36 preference based SF-6D in a clinical trial setting. Value Health. 2004, 7 (5): 602-609. 10.1111\/j.1524-4733.2004.75011.x.","journal-title":"Value Health"},{"issue":"10","key":"467_CR15","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s11136-004-6189-2","volume":"13","author":"D Feeny","year":"2004","unstructured":"Feeny D, Wu L, Eng K: Comparing short form 6D, standard gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: results from total hip arthroplasty patients. Qual Life Res. 2004, 13 (10): 1659-1670. 10.1007\/s11136-004-6189-2.","journal-title":"Qual Life Res"},{"issue":"2","key":"467_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2165\/00148365-200403020-00006","volume":"3","author":"GR Barton","year":"2004","unstructured":"Barton GR, Bankart J, Davis AC, Summerfield QA: Comparing Utility Scores Before and After Hearing-Aid Provision : Results According to the EQ-5D, HUI3 and SF-6D. Appl Health Econ Health Policy. 2004, 3 (2): 103-105. 10.2165\/00148365-200403020-00006.","journal-title":"Appl Health Econ Health Policy"},{"issue":"11","key":"467_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/hec.789","volume":"12","author":"BJ O'Brien","year":"2003","unstructured":"O'Brien BJ, Spath M, Blackhouse G, Severens JL, Dorian P, Brazier J: A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Econ. 2003, 12 (11): 975-981. 10.1002\/hec.789.","journal-title":"Health Econ"},{"issue":"2","key":"467_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2337\/diacare.29.02.06.dc05-1443","volume":"29","author":"ES Huang","year":"2006","unstructured":"Huang ES, Shook M, Jin L, Chin MH, Meltzer DO: The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care. 2006, 29 (2): 259-264. 10.2337\/diacare.29.02.06.dc05-1443.","journal-title":"Diabetes Care"},{"issue":"5)","key":"467_CR19","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/01.mlr.0000207464.61661.05","volume":"44","author":"P Franks","year":"2006","unstructured":"Franks P, Hanmer J, Fryback DG: Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample: toward consistency in cost-effectiveness analyses. Med Care. 2006, 44 (5)): 478-485.","journal-title":"Med Care"},{"key":"467_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1477-7525-3-11","volume":"3","author":"AS Pickard","year":"2005","unstructured":"Pickard AS, Wang Z, Walton SM, Lee TA: Are decisions using cost-utility analyses robust to choice of SF-36\/SF-12 preference-based algorithm?. Health Qual Life Outcomes. 2005, 3: 11-10.1186\/1477-7525-3-11.","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"467_CR21","first-page":"A109","volume":"7","author":"KJ Smith","year":"2010","unstructured":"Smith KJ, Hsu HE, Roberts MS, Kramer MK, Orchard TJ, Piatt GA, Seidel MC, Zgibor JC, Bryce CL: Cost-effectiveness analysis of efforts to reduce risk of type 2 diabetes and cardiovascular disease in southwestern Pennsylvania, 2005\u20132007. Prev Chronic Dis. 2010, 7 (5): A109.","journal-title":"Prev Chronic Dis"},{"issue":"5","key":"467_CR22","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jclinepi.2005.09.010","volume":"59","author":"SL Maddigan","year":"2006","unstructured":"Maddigan SL, Feeny DH, Majumdar SR, Farris KB, Johnson JA: Health Utilities Index mark 3 demonstrated construct validity in a population-based sample with type 2 diabetes. J Clin Epidemiol. 2006, 59 (5): 472-477. 10.1016\/j.jclinepi.2005.09.010.","journal-title":"J Clin Epidemiol"},{"key":"467_CR23","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1100\/tsw.2006.253","volume":"6","author":"F Mo","year":"2006","unstructured":"Mo F, Morrison H, Choi BC, Vardy L: Evaluation and measurement of health-related quality of life for individuals with diabetes mellitus by Health Utilities Index Mark 3 (HUI3) system. ScientificWorldJournal. 2006, 6: 1412-1423.","journal-title":"ScientificWorldJournal"},{"issue":"6","key":"467_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1177\/0272989X03258438","volume":"23","author":"SL Maddigan","year":"2003","unstructured":"Maddigan SL, Feeny DH, Johnson JA: A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes. Med Decis Making. 2003, 23 (6): 489-501. 10.1177\/0272989X03258438.","journal-title":"Med Decis Making"},{"issue":"3","key":"467_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10198-007-0068-z","volume":"9","author":"GR Barton","year":"2008","unstructured":"Barton GR, Sach TH, Doherty M, Avery AJ, Jenkinson C, Muir KR: An assessment of the discriminative ability of the EQ-5Dindex, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions. Eur J Health Econ. 2008, 9 (3): 237-249. 10.1007\/s10198-007-0068-z.","journal-title":"Eur J Health Econ"},{"issue":"12","key":"467_CR26","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1038\/oby.2009.114","volume":"17","author":"RT Ackermann","year":"2009","unstructured":"Ackermann RT, Edelstein SL, Venkat Narayan KM, Zhang P, Engelgau MM, Herman WH, Marrero DG: Changes in Health State Utilities With Changes in Body Mass in the Diabetes Prevention Program. Obesity (Silver Spring). 2009, 17 (12): 2176-2181. 10.1038\/oby.2009.114.","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"467_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.ijo.0803365","volume":"31","author":"TH Sach","year":"2007","unstructured":"Sach TH, Barton GR, Doherty M, Muir KR, Jenkinson C, Avery AJ: The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D. Int J Obes (Lond). 2007, 31 (1): 189-196. 10.1038\/sj.ijo.0803365.","journal-title":"Int J Obes (Lond)"},{"issue":"12A)","key":"467_CR28","doi-asserted-by":"publisher","first-page":"21i","DOI":"10.1016\/j.amjcard.2007.03.003","volume":"99","author":"JB Buse","year":"2007","unstructured":"Buse JB, Bigger JT, Byington RP, Cooper LS, Cushman WC, Friedewald WT, Genuth S, Gerstein HC, Ginsberg HN, Goff DC, et al: Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol. 2007, 99 (12A)): 21i-33i.","journal-title":"Am J Cardiol"},{"issue":"24","key":"467_CR29","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, et al: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008, 358 (24): 2545-2559.","journal-title":"N Engl J Med"},{"issue":"12A)","key":"467_CR30","doi-asserted-by":"publisher","first-page":"90i","DOI":"10.1016\/j.amjcard.2007.03.027","volume":"99","author":"MD Sullivan","year":"2007","unstructured":"Sullivan MD, Anderson RT, Aron D, Atkinson HH, Bastien A, Chen GJ, Feeney P, Gafni A, Hwang W, Katz LA, et al: Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design. Am J Cardiol. 2007, 99 (12A)): 90i-102i.","journal-title":"Am J Cardiol"},{"issue":"12A)","key":"467_CR31","doi-asserted-by":"publisher","first-page":"112i","DOI":"10.1016\/j.amjcard.2007.03.029","volume":"99","author":"JD Williamson","year":"2007","unstructured":"Williamson JD, Miller ME, Bryan RN, Lazar RM, Coker LH, Johnson J, Cukierman T, Horowitz KR, Murray A, Launer LJ: The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods. Am J Cardiol. 2007, 99 (12A)): 112i-122i.","journal-title":"Am J Cardiol"},{"issue":"2","key":"467_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier J, Roberts J, Deverill M: The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002, 21 (2): 271-292. 10.1016\/S0167-6296(01)00130-8.","journal-title":"J Health Econ"},{"key":"467_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1037\/1082-989X.1.1.30","volume":"1","author":"K McGraw","year":"1996","unstructured":"McGraw K, Wong S: Forming inferences about some Intraclass correlation coefficients. Psychol Methods. 1996, 1: 30-48.","journal-title":"Psychol Methods"},{"issue":"6","key":"467_CR34","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s11136-010-9828-9","volume":"20","author":"DJ O'Reilly","year":"2011","unstructured":"O'Reilly DJ, Xie F, Pullenayegum E, Gerstein HC, Greb J, Blackhouse GK, Tarride JE, Bowen J, Goeree RA: Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada. Qual Life Res. 2011, 20 (6): 939-943. 10.1007\/s11136-010-9828-9.","journal-title":"Qual Life Res"},{"key":"467_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1477-7525-5-21","volume":"5","author":"P Glasziou","year":"2007","unstructured":"Glasziou P, Alexander J, Beller E, Clarke P: Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes. 2007, 5: 21-10.1186\/1477-7525-5-21.","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"467_CR36","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/027298902400448902","volume":"22","author":"P Clarke","year":"2002","unstructured":"Clarke P, Gray A, Holman R: Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making. 2002, 22 (4): 340-349.","journal-title":"Med Decis Making"},{"issue":"3","key":"467_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/hec.910","volume":"14","author":"A Bagust","year":"2005","unstructured":"Bagust A, Beale S: Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Econ. 2005, 14 (3): 217-230. 10.1002\/hec.910.","journal-title":"Health Econ"},{"issue":"7","key":"467_CR38","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s11136-007-9226-0","volume":"16","author":"LS Matza","year":"2007","unstructured":"Matza LS, Boye KS, Yurgin N, Brewster-Jordan J, Mannix S, Shorr JM, Barber BL: Utilities and disutilities for type 2 diabetes treatment-related attributes. Qual Life Res. 2007, 16 (7): 1251-1265. 10.1007\/s11136-007-9226-0.","journal-title":"Qual Life Res"},{"issue":"1","key":"467_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1081\/COPD-200052090","volume":"2","author":"RM Kaplan","year":"2005","unstructured":"Kaplan RM: The minimally clinically important difference in generic utility-based measures. COPD. 2005, 2 (1): 91-97. 10.1081\/COPD-200052090.","journal-title":"COPD"},{"issue":"1","key":"467_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/0272989X0102100103","volume":"21","author":"A Robinson","year":"2001","unstructured":"Robinson A, Loomes G, Jones-Lee M: Visual analog scales, standard gambles, and relative risk aversion. Med Decis Making. 2001, 21 (1): 17-27. 10.1177\/0272989X0102100103.","journal-title":"Med Decis Making"},{"issue":"2","key":"467_CR41","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jhealeco.2005.09.003","volume":"25","author":"A Tsuchiya","year":"2005","unstructured":"Tsuchiya A, Brazier J, Roberts J: Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. J Health Econ. 2005, 25 (2): 334-346.","journal-title":"J Health Econ"},{"issue":"6","key":"467_CR42","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/art.22883","volume":"57","author":"F Xie","year":"2007","unstructured":"Xie F, Li SC, Luo N, Lo NN, Yeo SJ, Yang KY, Fong KY, Thumboo J: Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement. Arthritis Rheum. 2007, 57 (6): 1043-1049. 10.1002\/art.22883.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"467_CR43","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.socscimed.2004.08.034","volume":"60","author":"CA Marra","year":"2005","unstructured":"Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH: A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med. 2005, 60 (7): 1571-1582. 10.1016\/j.socscimed.2004.08.034.","journal-title":"Soc Sci Med"},{"issue":"4","key":"467_CR44","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1524-4733.2007.00174.x","volume":"10","author":"HL Wee","year":"2007","unstructured":"Wee HL, Machin D, Loke WC, Li SC, Cheung YB, Luo N, Feeny D, Fong KY, Thumboo J: Assessing differences in utility scores: a comparison of four widely used preference-based instruments. Value Health. 2007, 10 (4): 256-265. 10.1111\/j.1524-4733.2007.00174.x.","journal-title":"Value Health"},{"issue":"5","key":"467_CR45","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1046\/j.1524-4733.2001.45029.x","volume":"4","author":"A Lloyd","year":"2001","unstructured":"Lloyd A, Sawyer W, Hopkinson P: Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health. 2001, 4 (5): 392-400. 10.1046\/j.1524-4733.2001.45029.x.","journal-title":"Value Health"},{"issue":"3","key":"467_CR46","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1524-4733.2007.00260.x","volume":"11","author":"SL Dennett","year":"2008","unstructured":"Dennett SL, Boye KS, Yurgin NR: The impact of body weight on patient utilities with or without type 2 diabetes: a review of the medical literature. Value Health. 2008, 11 (3): 478-486. 10.1111\/j.1524-4733.2007.00260.x.","journal-title":"Value Health"},{"issue":"4","key":"467_CR47","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1177\/0272989X11409049","volume":"31","author":"AJ Hayes","year":"2011","unstructured":"Hayes AJ, Clarke PM, Voysey M, Keech A: Simulation of quality-adjusted survival in chronic diseases: an application in type 2 diabetes. Med Decis Making. 2011, 31 (4): 559-570. 10.1177\/0272989X11409049.","journal-title":"Med Decis Making"},{"key":"467_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1475-2840-9-7","volume":"9","author":"DA Belletti","year":"2010","unstructured":"Belletti DA, Zacker C, Wogen J: Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States. Cardiovasc Diabetol. 2010, 9: 7-10.1186\/1475-2840-9-7.","journal-title":"Cardiovasc Diabetol"},{"key":"467_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1475-2840-10-31","volume":"10","author":"A Kuznik","year":"2011","unstructured":"Kuznik A, Mardekian J: Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999\u20132008. Cardiovasc Diabetol. 2011, 10: 31-10.1186\/1475-2840-10-31.","journal-title":"Cardiovasc Diabetol"},{"key":"467_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1475-2840-10-5","volume":"10","author":"ML Norgaard","year":"2011","unstructured":"Norgaard ML, Andersson C, Hansen PR, Andersen SS, Vaag A, Schramm TK, Folke F, Kober L, Torp-Pedersen C, Gislason GH: Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006. Cardiovasc Diabetol. 2011, 10: 5-10.1186\/1475-2840-10-5.","journal-title":"Cardiovasc Diabetol"},{"key":"467_CR51","volume-title":"Diabet Med","author":"M Rahman","year":"2012","unstructured":"Rahman M, Simmons RK, Hennings SH, Wareham NJ, Griffin SJ: Effect of screening for Type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohort. Diabet Med. 2012, 28."}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2840-11-35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2840-11-35\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2840-11-35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T22:15:53Z","timestamp":1581977753000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/1475-2840-11-35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,19]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["467"],"URL":"https:\/\/doi.org\/10.1186\/1475-2840-11-35","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,19]]},"article-number":"35"}}